Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reyna Favis

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Pharmacogenetics and Genomics|January 14, 2011
Genetic variation associated with bortezomib-induced peripheral neuropathyReyna Favis, Yu Sun, Helgi van de Velde, et al.
Pharmacogenetics and Genomics|February 26, 2015
Large-scale candidate gene study to identify genetic risk factors predictive of paliperidone treatment response in patients with schizophreniaDai Wang, Dong-Jing Fu, Xiaodong Wu, et al.
BMC Genetics|April 1, 2009
Robust physical methods that enrich genomic regions identical by descent for linkage studies: confirmation of a locus for osteogenesis imperfectaPeter Brooks, Charles Marcaillou, Maud Vanpeene, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Rapid and sensitive p53 alteration analysis in biopsies from lung cancer patients using a functional assay and a universal oligonucleotide array: a prospective studyCoralie Fouquet, Martine Antoine, Pascaline Tisserand, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 28, 2009
A randomized phase 2 study of erlotinib alone and in combination with bortezomib in previously treated advanced non-small cell lung cancerThomas J Lynch, David Fenton, Vera Hirsh, et al.
Neuropharmacology|July 7, 2012
Allosteric alpha-7 nicotinic receptor modulation and P50 sensory gating in schizophrenia: a proof-of-mechanism studyGeorg Winterer, Jürgen Gallinat, Jürgen Brinkmeyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2013
Prespecified candidate biomarkers identify follicular lymphoma patients who achieved longer progression-free survival with bortezomib-rituximab versus rituximabBertrand Coiffier, Weimin Li, Erin D Henitz, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Pharmacogenetics and Genomics|January 14, 2011
Genetic variation associated with bortezomib-induced peripheral neuropathyReyna Favis, Yu Sun, Helgi van de Velde, et al.
Pharmacogenetics and Genomics|February 26, 2015
Large-scale candidate gene study to identify genetic risk factors predictive of paliperidone treatment response in patients with schizophreniaDai Wang, Dong-Jing Fu, Xiaodong Wu, et al.
BMC Genetics|April 1, 2009
Robust physical methods that enrich genomic regions identical by descent for linkage studies: confirmation of a locus for osteogenesis imperfectaPeter Brooks, Charles Marcaillou, Maud Vanpeene, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Rapid and sensitive p53 alteration analysis in biopsies from lung cancer patients using a functional assay and a universal oligonucleotide array: a prospective studyCoralie Fouquet, Martine Antoine, Pascaline Tisserand, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 28, 2009
A randomized phase 2 study of erlotinib alone and in combination with bortezomib in previously treated advanced non-small cell lung cancerThomas J Lynch, David Fenton, Vera Hirsh, et al.
Neuropharmacology|July 7, 2012
Allosteric alpha-7 nicotinic receptor modulation and P50 sensory gating in schizophrenia: a proof-of-mechanism studyGeorg Winterer, Jürgen Gallinat, Jürgen Brinkmeyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2013
Prespecified candidate biomarkers identify follicular lymphoma patients who achieved longer progression-free survival with bortezomib-rituximab versus rituximabBertrand Coiffier, Weimin Li, Erin D Henitz, et al.
Pageof 2